FR1525186A
(fr)
|
1967-03-29 |
1968-05-17 |
Roussel Uclaf |
Nouvelles pénicillines et procédé de préparation
|
EP0028489B1
(en)
|
1979-11-05 |
1983-10-05 |
Beecham Group Plc |
Enzyme derivatives, and their preparation
|
DE4034829A1
(de)
|
1990-11-02 |
1992-05-07 |
Merck Patent Gmbh |
Cyclopeptide
|
JP3190431B2
(ja)
|
1991-07-01 |
2001-07-23 |
三菱化学株式会社 |
ケトン誘導体
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
WO1996034010A2
(en)
|
1995-03-29 |
1996-10-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5624936A
(en)
|
1995-03-29 |
1997-04-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5869682A
(en)
|
1996-04-03 |
1999-02-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
CA2249617A1
(en)
|
1996-04-03 |
1997-10-09 |
S. Jane Desolms |
Inhibitors of farnesyl-protein transferase
|
PE121699A1
(es)
|
1997-02-18 |
1999-12-08 |
Boehringer Ingelheim Pharma |
Heterociclos biciclicos disustituidos como inhibidores de la trombina
|
ZA985247B
(en)
|
1997-06-19 |
1999-12-17 |
Du Pont Merck Pharma |
Guanidine mimics as factor Xa inhibitors.
|
TW557297B
(en)
|
1997-09-26 |
2003-10-11 |
Abbott Lab |
Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same
|
RU2274642C2
(ru)
|
1998-03-19 |
2006-04-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы каспаз
|
DE69939168D1
(de)
|
1998-05-26 |
2008-09-04 |
Warner Lambert Co |
Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
HUP0105437A3
(en)
|
1999-01-02 |
2003-03-28 |
Aventis Pharma Gmbh |
Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
|
EP1016663A1
(en)
|
1999-01-02 |
2000-07-05 |
Aventis Pharma Deutschland GmbH |
Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
|
MXPA01010114A
(es)
|
1999-04-09 |
2002-07-30 |
Basf Ag |
Inhibidores de peso molecular bajo de las proteasas complemento.
|
EP1192135A2
(en)
|
1999-06-14 |
2002-04-03 |
Eli Lilly And Company |
Serine protease inhibitors
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
EP1125925A1
(en)
|
2000-02-15 |
2001-08-22 |
Applied Research Systems ARS Holding N.V. |
Amine derivatives for the treatment of apoptosis
|
EP1280777B1
(en)
|
2000-05-11 |
2005-11-23 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
AR035216A1
(es)
|
2000-12-01 |
2004-05-05 |
Astrazeneca Ab |
Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
|
WO2003011222A2
(en)
|
2001-07-27 |
2003-02-13 |
Merck & Co., Inc. |
Thrombin inhibitors
|
US6951840B2
(en)
|
2001-08-31 |
2005-10-04 |
Eli Lilly And Company |
Lipoglycopeptide antibiotics
|
RU2345993C2
(ru)
|
2001-09-21 |
2009-02-10 |
Бристол-Маерс Сквибб Компани |
ЛАКТАМСОДЕРЖАЩЕЕ СОЕДИНЕНИЕ И ЕГО ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa
|
US6649606B1
(en)
|
2001-11-09 |
2003-11-18 |
Bristol-Myers Squibb Co. |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
WO2003106438A1
(en)
|
2002-06-18 |
2003-12-24 |
The Scripps Research Institute |
Synthesis of diazonamide "a" core
|
US20040180855A1
(en)
|
2003-02-19 |
2004-09-16 |
Schumacher William A. |
Methods of treating thrombosis with reduced risk of increased bleeding times
|
US7138412B2
(en)
|
2003-03-11 |
2006-11-21 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives useful as serine protease inhibitors
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
WO2005014533A2
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
US7417063B2
(en)
|
2004-04-13 |
2008-08-26 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles useful as serine protease inhibitors
|
US7453002B2
(en)
|
2004-06-15 |
2008-11-18 |
Bristol-Myers Squibb Company |
Five-membered heterocycles useful as serine protease inhibitors
|
US7429604B2
(en)
|
2004-06-15 |
2008-09-30 |
Bristol Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
BRPI0513310A
(pt)
|
2004-07-12 |
2008-05-06 |
Idun Pharmaceuticals Inc |
análogos de tetrapeptìdeo
|
US7459564B2
(en)
|
2005-01-13 |
2008-12-02 |
Bristol-Myers Squibb Company |
Substituted biaryl compounds as factor XIa inhibitors
|
US20060183771A1
(en)
|
2005-02-17 |
2006-08-17 |
Seiffert Dietmar A |
Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors
|
WO2007047608A2
(en)
|
2005-10-14 |
2007-04-26 |
Epix Pharmaceuticals, Inc. |
Fibrin targeted therapeutics
|
KR20080067697A
(ko)
|
2005-11-11 |
2008-07-21 |
에프. 호프만-라 로슈 아게 |
응고 인자 xa의 억제제로서 카보사이클릭 융합된사이클릭 아민
|
US8163749B2
(en)
|
2005-12-14 |
2012-04-24 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
US8466295B2
(en)
|
2005-12-14 |
2013-06-18 |
Bristol-Myers Squibb Company |
Thiophene derivatives as factor XIa inhibitors
|
NZ568595A
(en)
|
2005-12-14 |
2010-04-30 |
Bristol Myers Squibb Co |
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
|
AR058380A1
(es)
|
2005-12-23 |
2008-01-30 |
Bristol Myers Squibb Co |
Inhibidores del factor viia macrociclicos utiles como anticoagulantes
|
JP5342450B2
(ja)
|
2006-12-15 |
2013-11-13 |
ブリストル−マイヤーズ スクイブ カンパニー |
第XIa因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ
|
PE20081775A1
(es)
|
2006-12-20 |
2008-12-18 |
Bristol Myers Squibb Co |
Compuestos macrociclicos como inhibidores del factor viia
|
AU2008266228A1
(en)
|
2007-06-13 |
2008-12-24 |
Bristol-Myers Squibb Company |
Dipeptide analogs as coagulation factor inhibitors
|
JP5537442B2
(ja)
|
2008-03-13 |
2014-07-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
第xia因子阻害剤としてのピリダジン誘導体
|
US8624040B2
(en)
|
2009-06-22 |
2014-01-07 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
US8513433B2
(en)
|
2009-07-02 |
2013-08-20 |
Angion Biomedica Corp. |
Small molecule inhibitors of PARP activity
|
US8609676B2
(en)
|
2009-08-04 |
2013-12-17 |
Merck Sharp & Dohme, Corp. |
4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors
|
WO2011100401A1
(en)
|
2010-02-11 |
2011-08-18 |
Bristol-Myers Squibb Company |
Macrocycles as factor xia inhibitors
|
US9161924B2
(en)
|
2011-07-08 |
2015-10-20 |
Merck Sharp & Dohme Corp. |
Factor IXa inhibitors
|
TW201311689A
(zh)
|
2011-08-05 |
2013-03-16 |
必治妥美雅史谷比公司 |
作為因子xia抑制劑之新穎巨環化合物
|
TW201319068A
(zh)
*
|
2011-08-05 |
2013-05-16 |
必治妥美雅史谷比公司 |
作為xia因子抑制劑之環狀p1接合劑
|
US9079929B2
(en)
|
2011-10-14 |
2015-07-14 |
Bristol-Myers Squibb Company |
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
|
HUE034857T2
(en)
|
2011-10-14 |
2018-03-28 |
Bristol Myers Squibb Co |
Substituted tetrahydroisoquinoline compounds are inhibitors of factor XIA
|
ES2572908T3
(es)
|
2011-10-14 |
2016-06-03 |
Bristol-Myers Squibb Company |
Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor XIa
|
GB2497806A
(en)
|
2011-12-21 |
2013-06-26 |
Ono Pharmaceutical Co |
Pyridinone and pyrimidinone derivatives as factor XIa inhibitors
|
ES2765891T3
(es)
|
2011-12-21 |
2020-06-11 |
Ono Pharmaceutical Co |
Derivados de piridinona y pirimidinona como inhibidores del factor XIa
|
EP2807156A1
(en)
|
2012-01-27 |
2014-12-03 |
Novartis AG |
Aminopyridine derivatives as plasma kallikrein inhibitors
|
EP2807157A1
(en)
|
2012-01-27 |
2014-12-03 |
Novartis AG |
5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
3位置換プロリン誘導体
|
JP6348900B2
(ja)
|
2012-05-10 |
2018-06-27 |
バイエル ファーマ アクチエンゲゼルシャフト |
凝固因子xiおよび/またはその活性化形態である因子xiaに結合しうる抗体ならびにその用途
|
GB201209138D0
(en)
|
2012-05-24 |
2012-07-04 |
Ono Pharmaceutical Co |
Compounds
|
AU2013291098A1
(en)
|
2012-07-19 |
2015-02-05 |
Sumitomo Dainippon Pharma Co., Ltd. |
1-(cycloalkyl-carbonyl)proline derivative
|
JP6082463B2
(ja)
*
|
2012-08-03 |
2017-02-15 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
第xia因子阻害剤としてのジヒドロピリドンp1
|
BR112015002293A2
(pt)
*
|
2012-08-03 |
2017-07-04 |
Bristol Myers Squibb Co |
di-hidropiridona pi como inibidores do fator xia
|
EP2906551B1
(en)
|
2012-10-12 |
2018-02-28 |
Bristol-Myers Squibb Company |
Crystalline forms of a factor xia inhibitor
|
WO2014059202A1
(en)
|
2012-10-12 |
2014-04-17 |
Bristol-Myers Squibb Company |
Guanidine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
EP2906541B1
(en)
|
2012-10-12 |
2017-11-22 |
Bristol-Myers Squibb Company |
Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
US9708308B2
(en)
|
2012-12-19 |
2017-07-18 |
Merck Sharp Dohme Corp. |
Factor IXa inhibitors
|
GB201300304D0
(en)
|
2013-01-08 |
2013-02-20 |
Kalvista Pharmaceuticals Ltd |
Benzylamine derivatives
|
GB2510407A
(en)
|
2013-02-04 |
2014-08-06 |
Kalvista Pharmaceuticals Ltd |
Aqueous suspensions of kallikrein inhibitors for parenteral administration
|
JP6479763B2
(ja)
|
2013-03-25 |
2019-03-06 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
第xia因子阻害剤としての置換アゾール含有のテトラヒドロイソキノリン
|
TWI633089B
(zh)
|
2013-03-28 |
2018-08-21 |
拜耳製藥股份有限公司 |
經取代的酮基吡啶衍生物
|
CA2918814C
(en)
|
2013-07-23 |
2021-10-12 |
Bayer Pharma Aktiengesellschaft |
Substituted oxopyridine derivatives and use thereof as factor xia/plasma
|
EP3049394A1
(de)
|
2013-09-26 |
2016-08-03 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate als faktor xia modulatoren
|
WO2015044169A1
(de)
|
2013-09-26 |
2015-04-02 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate
|
US20160237044A1
(en)
|
2013-09-26 |
2016-08-18 |
Bayer Pharma Aktiengesellschaft |
Substituted phenylalanine derivatives
|
CN105745192A
(zh)
|
2013-09-26 |
2016-07-06 |
拜耳制药股份公司 |
取代的苯丙氨酸衍生物
|
EP3049404A1
(de)
|
2013-09-26 |
2016-08-03 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate
|
US20160280699A1
(en)
|
2013-09-26 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Substituted phenylalanine derivatives
|
WO2015044173A1
(de)
|
2013-09-26 |
2015-04-02 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate als faktor xia modulatoren
|
UY35747A
(es)
|
2013-09-26 |
2015-04-30 |
Bayer Pharma AG |
Derivados sustituidos de fenilalanina
|
WO2015047973A1
(en)
|
2013-09-27 |
2015-04-02 |
Merck Sharp & Dohme Corp. |
FACTOR XIa INHIBITORS
|
US20160257668A1
(en)
|
2013-10-07 |
2016-09-08 |
Merck Sharp & Dohme Corp. |
Factor XIa Inhibitors
|
JP6337750B2
(ja)
|
2013-11-22 |
2018-06-06 |
小野薬品工業株式会社 |
化合物
|
CA2939326A1
(en)
|
2014-01-14 |
2015-07-23 |
Sumitomo Dainippon Pharma Co., Ltd. |
Condensed 5-oxazolidinone derivative
|
CN106132962B
(zh)
|
2014-01-31 |
2018-09-07 |
百时美施贵宝公司 |
作为凝血因子xia抑制剂的具有芳族p2’基团的大环化合物
|
NO2760821T3
(US07585860-20090908-C00136.png)
|
2014-01-31 |
2018-03-10 |
|
|
ES2945905T3
(es)
|
2014-02-07 |
2023-07-10 |
Exithera Pharmaceuticals Inc |
Compuestos y composiciones terapéuticos
|
EP3104702B1
(en)
|
2014-02-11 |
2022-08-10 |
Merck Sharp & Dohme LLC |
Factor xia inhibitors
|
US9944643B2
(en)
|
2014-02-11 |
2018-04-17 |
Merck Sharp & Dohme Corp. |
Factor XIa inhibitors
|
US9663527B2
(en)
|
2014-02-11 |
2017-05-30 |
Merck Sharp & Dohme Corp. |
Factor XIa inhibitors
|
WO2015120777A1
(zh)
|
2014-02-14 |
2015-08-20 |
四川海思科制药有限公司 |
一种吡啶酮或嘧啶酮衍生物、及其制备方法和应用
|
EA036251B1
(ru)
|
2014-03-07 |
2020-10-20 |
Байокрист Фармасьютикалз, Инк. |
Ингибиторы калликреина плазмы человека
|
WO2015160636A1
(en)
|
2014-04-16 |
2015-10-22 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
WO2015160634A1
(en)
|
2014-04-16 |
2015-10-22 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
KR20150136294A
(ko)
|
2014-05-27 |
2015-12-07 |
주식회사 레고켐 바이오사이언스 |
인자 XIa 억제 활성을 가지는 신규한 화합물
|
CN106413710A
(zh)
|
2014-05-28 |
2017-02-15 |
默沙东公司 |
因子XIa抑制剂
|
ES2712886T3
(es)
|
2014-09-24 |
2019-05-16 |
Bayer Pharma AG |
Derivados de piridobenzazepina y piridobenzazocina que inhiben el factor XIa
|
US9453018B2
(en)
|
2014-10-01 |
2016-09-27 |
Bristol-Myers Squibb Company |
Pyrimidinones as factor XIa inhibitors
|
NO2721243T3
(US07585860-20090908-C00136.png)
|
2014-10-01 |
2018-10-20 |
|
|
BR112017012146B1
(pt)
|
2014-12-10 |
2023-11-21 |
Ono Pharmaceutical Co., Ltd |
Composto derivado de di-hidroindolizinona, seu uso, composição farmacêutica e inibidor de fxia
|
ES2762987T3
(es)
|
2015-06-19 |
2020-05-26 |
Bristol Myers Squibb Co |
Macrociclos de diamida como inhibidores del factor XIA
|